Search

everythinglearnresearchcommunity

for

Search:↓

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Replenishing free 18-MEA can help restore damaged hair surfaces.

Polynucleotides improve skin quality and are safe and effective for rejuvenation.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.

Self-assembling RADA16-I hydrogels with bioactive peptides significantly improve wound healing.

PRP is more effective than triamcinolone for treating alopecia areata.

Lack of FPR2 slows hair growth by affecting hair cell activity.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Tofacitinib, a hair regrowth treatment, may worsen acne.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

KGF and activin are crucial for skin healing and repair.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Trichohyalin in hair can trigger immune attacks in alopecia areata.

No effective treatment exists to stimulate hair growth in atrichia with papular lesions.

Tretinoin is used topically to treat acne, skin aging, and various skin conditions.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

The acne treatment improved skin texture and acne lesions but not scars.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.